10X Genomics
Pleasanton
CA
94566
United States
142 articles with 10X Genomics
-
10x Genomics Reports First Quarter 2022 Financial Results
5/4/2022
10x Genomics, Inc. reported financial results for the first quarter ended March 31, 2022.
-
10x Genomics to Present at the BofA Securities 2022 Healthcare Conference
4/26/2022
10x Genomics, Inc., a life sciences leader focused on mastering biology to advance human health, announced the company will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada.
-
10x Genomics Launches Two New Products to Unlock Wider Range of Samples for Single Cell Analysis on Chromium
4/14/2022
10x Genomics today announced the commercial availability of two new products designed to improve sample preparation workflow and broaden the adoption of the company's leading Chromium platform for single cell analysis.
-
10x Genomics to Report First Quarter Financial Results on May 4, 2022
4/7/2022
10x Genomics announced it will report financial results for the first quarter 2022 after market close on Wednesday, May 4, 2022.
-
10x Genomics to Present at the Cowen 42nd Annual Health Care Conference
3/1/2022
10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be participating in the upcoming Cowen 42nd Annual Health Care Conference.
-
Element Biosciences Becomes the Newest Member of 10x Genomics’ Compatible Partner Program (CPP) Across Multiple Single Cell Applications
2/28/2022
Element Biosciences, Inc. today announced a partnership with 10x Genomics that demonstrates the seamless integration of the Element AVITI ™ System and 10x Genomics’ single cell technologies.
-
10x Genomics Showcases Robust Innovation Pipeline at Xperience 2022 Event
2/22/2022
10x Genomics, Inc., a life sciences leader focused on mastering biology to advance human health, unveiled new details about upcoming products and capabilities across its single cell, spatial, and in situ platforms at its second annual Xperience 2022 virtual event.
-
10x Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Outlook for 2022
2/16/2022
10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the fourth quarter and full year ended December 31, 2021 and provided outlook for 2022.
-
Psomagen, Inc. Makes Key Tools and Technologies Accessible and Scalable Through Partnerships With 10x Genomics and Olink Proteomics
1/20/2022
After finalizing partnerships with 10x Genomics and Olink Proteomics in 2021, Psomagen, Inc., is beginning 2022 by bringing end-to-end multiomics solutions to the drug discovery and development, diagnostics, and clinical research industries.
-
10x Genomics to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
12/22/2021
10x Genomics, Inc. (Nasdaq: TXG) today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.
-
10x Genomics Recognized on The Scientist's Top 10 Innovations List for Fifth Consecutive Year
12/1/2021
10x Genomics, a life sciences leader focused on mastering biology to advance human health, announced that Chromium X has been named one of The Scientist's 2021 Top 10 Innovations, an annual list of newly released products that have the potential to generate the biggest impact on scientific research.
-
This year’s top 30 large and small companies operate in some of the Life Sciences’ hottest spaces – precision medicine, vaccines, gene editing, genomics and oncology.
-
10x Genomics Reports Third Quarter 2021 Financial Results
11/3/2021
10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2021.
-
The life sciences industry continues to be one of the fastest growing industries in the world as the end of the year draws near.
-
10X Genomics is continuing to increase its presence outside of the United States, this time with its first manufacturing facility outside of the country.
-
10x Genomics to Report Third Quarter Financial Results on November 3, 2021
10/7/2021
10x Genomics announced it will report financial results for the third quarter 2021 after market close on Wednesday, November 3rd, 2021.
-
10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
8/31/2021
10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference.
-
10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit
8/6/2021
10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit.
-
10x Genomics Reports Second Quarter 2021 Financial Results
8/4/2021
10x Genomics, Inc. reported financial results for the second quarter ended June 30, 2021.
-
10x Genomics to Report Second Quarter Financial Results on August 4, 2021
7/7/2021
10x Genomics announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4th, 2021.